Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • m1gre
    Junior Member
    • Sep 2011
    • 3

    #1

    Exon duplication & deletions

    Hi,

    We're soon to be getting a MiSeq and one of our first projects is to look at a small number of genes for a large number of patients.

    We need to be able to identify point mutations but also hoping to be able to detect whole exon duplication/deletions by measuring read depth.

    Can anyone help with what would be the best library prep method for this and also what sort of read depth should we be looking at to be able to quantify our dup/dels.

    Thanks,
  • ulz_peter
    Senior Member
    • Feb 2010
    • 219

    #2
    are you planning to do target enrichment or amplicon sequencing?

    I guess exon duplication/deletion analysis is impossible for amplicon sequencing (as you need to normalize PCR products...), unless the patient as a homozygous exon deletion (which is highly unlikely).

    For target enrichment it's not entirely unfeasible but due to pre-capture, and post-capture amplification, as well as different hybridization efficiencies I don't think it is easy to correlate read-depth to number of template alleles...

    However, as I never did Illumina sequencing myself, there might be other options that could work. If you've found a solution I would be happy to hear from, since we are waiting for a MiSeq as well.

    Comment

    • m1gre
      Junior Member
      • Sep 2011
      • 3

      #3
      Thanks for the reply,

      Our plan was target enrichment as I thought this may be more feasible than the amplicon sequencing for quantitation. Was wondering if the SureSelect or Nextera might be an option. I'll contact Illumina tech support to see if they can help any further.

      Comment

      • ulz_peter
        Senior Member
        • Feb 2010
        • 219

        #4
        Nextera isn't a target enrichment alternative, it is an alternative way to prepare the library for sequencing (however, for Illumina I think it is now the official way, as they bought the company which produced Nextera reagents).

        Sureselect should work fine, but with all the mplifications you still get the bias making it hard to correlate.

        Comment

        • GW_OK
          Senior Member
          • Sep 2009
          • 411

          #5
          I'd go with Illumina's new targeted cap system. It's a lot cheaper than Sureselect. As far the duplications go, were you thinking something like FPKM or something, ala RNAseq?

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          40 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...